ORACLE: observational ctDNA surveillance across early-stage solid tumors
Observational study of a ctDNA assay for recurrence detection after curative-intent treatment, with cohorts in bladder, lung, breast, melanoma, gastroesophageal, gastric, pancreatic, head and neck, ovarian, endometrial, kidney, and colorectal cancers. ClinicalTrials.gov lists the study as recruiting.
Guardant Health, Inc.